Harvard Bioscience, Inc.
HBIONASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $37.25M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.40$8.80
- Volume (live)
- -
- Avg. volume (3M)
- 17.21K
Harvard Bioscience (HBIO) Stock Price & Financial Analysis
Harvard Bioscience Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.10 - $8.40 |
|---|---|
| 52-Week High | $8.80 |
| 52-Week Low | $0.40 |
| Open | $8.13 |
| Volume (last close) | 26.99K |
| Average Volume (3M) | 17.21K |
| Revenue (TTM) | 87.81M |
|---|---|
| Net Income (TTM) | -10.41M |
| Free Cash Flow (TTM) | -1.64M |
| EPS (TTM) | −$2.33 |
| Profit Margin | -11.86% |
| Operating Margin | 1.59% |
| Return on Equity (ROE) | -140.36% |
| Debt to Equity | 5.16 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 37.25M |
|---|---|
| Shares Outstanding | 4.53M |
| Price to Sales (P/S) | 0.42 |
| Price to Book (P/B) | 5.02 |
| EV/EBITDA | -39.66 |
| 50-Day MA | $7.84 |
|---|---|
| 200-Day MA | $6.35 |
| 1-Year Change | +1965.38% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Harvard Bioscience at a Glance
As of the Oct 23, 2026 close, Harvard Bioscience (HBIO) has a market capitalization of $37.25M. The stock trades at 0.4× sales. Over the trailing twelve months it lost $10.41M on revenue of $87.81M and burned $1.64M of free cash flow. Revenue fell 1.1% year over year.
As of its latest reported balance sheet, it holds $6.50M in cash and securities against $38.28M of debt, a net debt position of $31.78M.
Harvard Bioscience does not currently pay a dividend.
The share price is up 1965.4% over the past year. At $8.23 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $0.40 to $8.80, above its 200-day moving average of $6.35.
Frequently Asked Questions About Harvard Bioscience
What is the current stock price for HBIO?
As of the Oct 23, 2026 close, HBIO stock trades at $8.23. The 52-week range is $0.40–$8.80, with a day range of $8.10–$8.40.
What is the P/E ratio for HBIO?
The P/E ratio (Price-to-Earnings) for HBIO is shown in the Key Statistics section. This valuation metric helps compare Harvard Bioscience, Inc. to industry peers.
Does HBIO pay dividends?
Harvard Bioscience does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for HBIO?
Analyst ratings and recommendations for HBIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of HBIO?
As of the Oct 23, 2026 close, Harvard Bioscience's market capitalization is $37.2M, classifying it as a micro-cap company. Harvard Bioscience operates in the Healthcare sector within the Medical Instruments & Supplies industry.